BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28368486)

  • 1. Pulsatile GnRH Therapy May Restore Hypothalamus-Pituitary-Testis Axis Function in Patients With Congenital Combined Pituitary Hormone Deficiency: A Prospective, Self-Controlled Trial.
    Zheng J; Mao J; Xu H; Wang X; Huang B; Liu Z; Cui M; Xiong S; Ma W; Min L; Kaiser UB; Nie M; Wu X
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2291-2300. PubMed ID: 28368486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for pituitary response to pulsatile GnRH therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF; Wang X; Zheng JJ; Liu ZX; Xu HL; Huang BK; Nie M; Wu XY
    Asian J Androl; 2018; 20(4):319-323. PubMed ID: 29516878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of pulsatile GnRH therapy on pituitary-testicular axis function in male patients with pituitary stalk interruption syndrome].
    Zheng JJ; Mao JF; Wu XY; Wang X; Liu ZX; Huang BK
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(21):1668-72. PubMed ID: 27290707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Pulsatile Gonadotropin-Releasing Hormone Therapy in Male Patients: Comparison between Pituitary Stalk Interruption Syndrome and Congenital Hypogonadotropic Hypogonadism.
    Huang Q; Mao J; Wang X; Yu B; Ma W; Ji W; Zhu Y; Zhang R; Sun B; Zhang J; Nie M; Wu X
    Endocr Pract; 2022 May; 28(5):521-527. PubMed ID: 35218954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
    Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of pulsatile gonadotropin-releasing hormone therapy in male patients with hypogonadism caused by hypopituitarism.
    Gu Y; Zhang S; Li X; Dou J; Lyu Z; Ba J; Guo Q; Zang L; Chen K; Du J; Pei Y; Mu Y; Gu W
    Ann Palliat Med; 2021 Apr; 10(4):4642-4651. PubMed ID: 33966412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes.
    Sykiotis GP; Hoang XH; Avbelj M; Hayes FJ; Thambundit A; Dwyer A; Au M; Plummer L; Crowley WF; Pitteloud N
    J Clin Endocrinol Metab; 2010 Jun; 95(6):3019-27. PubMed ID: 20382682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital combined pituitary hormone deficiency patients have better responses to gonadotrophin-induced spermatogenesis than idiopathic hypogonadotropic hypogonadism patients.
    Mao J; Xu H; Wang X; Huang B; Liu Z; Zhen J; Nie M; Min L; Wu X
    Hum Reprod; 2015 Sep; 30(9):2031-7. PubMed ID: 26141714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulsatile Gonadotropin-Releasing Hormone Therapy Is Associated With Better Spermatogenic Outcomes than Gonadotropin Therapy in Patients With Pituitary Stalk Interruption Syndrome.
    Zhang J; Zhu Y; Zhang R; Liu H; Sun B; Zhang W; Wang X; Nie M; Mao J; Wu X
    Endocr Pract; 2024 Feb; 30(2):146-154. PubMed ID: 38029930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed puberty in males with beta-thalassemia major: pulsatile gonadotropin-releasing hormone administration induces changes in gonadotropin isoform profiles and an increase in sex steroids.
    Valenti S; Giusti M; McGuinness D; Guido R; Mori PG; Giordano G; Dahl KD
    Eur J Endocrinol; 1995 Jul; 133(1):48-56. PubMed ID: 7627337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dysfunction of hypothalamic-pituitary-testicular axis in patients with adrenal hypoplasia congenita due to DAX-1 gene mutation].
    Zheng JJ; Wu XY; Nie M; Liu ZX; Wang X; Huang BK; Fu Y; Lu L; Duan L; Mao JF
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1183-7. PubMed ID: 27117364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary and gonadal responses to the long-term pulsatile administration of gonadotrophin-releasing hormone in fetal sheep.
    Thomas GB; Brooks AN
    J Endocrinol; 1997 Jun; 153(3):385-91. PubMed ID: 9203992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulsatile gonadotropin secretion after discontinuation of long term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men.
    Finkelstein JS; Spratt DI; O'Dea LS; Whitcomb RW; Klibanski A; Schoenfeld DA; Crowley WF
    J Clin Endocrinol Metab; 1989 Aug; 69(2):377-85. PubMed ID: 2502554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of male hypogonadotropic hypogonadism and constitutional delay of puberty by pulsatile administration of gonadotropin-releasing hormone.
    Partsch CJ; Hermanussen M; Sippell WG
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1196-203. PubMed ID: 3923024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibin B secretion in males with gonadotropin-releasing hormone (GnRH) deficiency before and during long-term GnRH replacement: relationship to spontaneous puberty, testicular volume, and prior treatment--a clinical research center study.
    Nachtigall LB; Boepple PA; Seminara SB; Khoury RH; Sluss PM; Lecain AE; Crowley WF
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3520-5. PubMed ID: 8855795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-week pulsatile gonadotropin releasing hormone infusion unmasks dual (hypothalamic and Leydig cell) defects in the healthy aging male gonadotropic axis.
    Mulligan T; Iranmanesh A; Kerzner R; Demers LW; Veldhuis JD
    Eur J Endocrinol; 1999 Sep; 141(3):257-66. PubMed ID: 10474123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of puberty in a patient with hypogonadotropic hypogonadism: effect of sequentially applied hCG and pulsatile GnRH administration.
    Klingmüller D; Menger D; Wildt L; Leyendecker G; Krück F; Schweikert HU
    Horm Metab Res; 1985 Jul; 17(7):358-61. PubMed ID: 3928472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-responsiveness of serum gonadotropins and testosterone to pulsatile GnRH in hemochromatosis suggesting a pituitary defect.
    Duranteau L; Chanson P; Blumberg-Tick J; Thomas G; Brailly S; Lubetzki J; Schaison G; Bouchard P
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):351-4. PubMed ID: 8498154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.